EpiCept epicept.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1148)

EpiCept is focused on unmet needs in the treatment of pain and cancer. The Company's portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead oncology compound for AML with demonstrated efficacy in a Phase III trial; a marketing authorization application for this compound is approaching a decision in Europe. In addition, EpiCept's ASAP technology, a proprietary live cell high-throughput caspase-3 screening technology, can efficiently ident...Show all

EpiCept is focused on unmet needs in the treatment of pain and cancer. The Company's portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead oncology compound for AML with demonstrated efficac...Show all

Company (Merged)

Phone: 914-606-3500

Fax:

777 Old Saw Mill River Road

Tarrytown, 10591
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
EpiCept $66.9M Aug 26, 2013
See all 36 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related EpiCept Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Domain AssociatesVenture CapitalPrinceton, New Jersey, United StatesPIPE - II, Unattributed VC - IV
AlpInvest PartnersPrivate EquityAmsterdam, Netherlands
Alexandra Investment ManagementUnattributed VC - IV
Bushido Capital PartnersHedge FundNew York, New York, United StatesUnattributed VC - IV
Bristol Capital AdvisorsAsset/Investment ManagementLos Angeles, California, United StatesPIPE - III, Unattributed VC - IV
See all 21 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 36 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof Jul 03, 2007 Nov 30, 2010 Patent